Form 4 Tracker
Greg Keenan

SVP, Chief Medical Officer · 3 filings · Latest: Mar 6, 2026

Aurinia Pharmaceuticals Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AUPH
GREGORY KEENANJun 5, 2026
Proposed Sale
$16.529,593$158.5K
AUPH
GREGORY KEENANJun 4, 2026
Proposed Sale
$16.3425,000$408.4K
AUPH
GREGORY KEENANJun 2, 2026
Proposed Sale
$2,164.0025,000$54.1M